期刊文献+

老年终末期肿瘤患者血浆脑利钠肽前体水平变化及其临床意义 被引量:1

Change of plasmic pro-BNP level and its clinical significance in presby-tumor patients
下载PDF
导出
摘要 目的探讨老年肿瘤患者血浆脑利钠肽前体(pro-BNP)水平的变化及其临床意义。方法选取36例肿瘤患者为实验组,另选取同期住院非肿瘤患者20例为对照组。分别于入院第1天和第14天对患者心功能分级、检测2组患者血浆pro-BNP浓度及左心室射血分数(LVEF),分别观察2个时间点各指标间的差异。结果入院第1天肿瘤组患者心功能评分、LVEF与对照组差异无统计学意义,入院第14天肿瘤组患者心功能、LVEF显著低于对照组,差异有统计学意义(P<0.05);入院第1天和第14天肿瘤组患者血浆pro-BNP浓度均显著高于对照组,差异有统计学意义(P<0.01)。结论血浆pro-BNP水平能较准确地反映老年肿瘤患者左室功能状态,其敏感性高于超声心动图,对老年住院患者心力衰竭的风险评估具有早期应用价值。 Objective To investigate the change of plasmic pro-BNP level and its clinical significance in presby-tumor patients. Methods Forty patients were divided into the tumor group and control group, At 1d and 14d after hospitalization, the class of heart function was decided and the LVEF was checked, individually. Results At ld after hospitalization, there were no apparent differences about the score of heart function and LVEF between the two groups. But at 14d, the score of heart function and LVEF in the tumor group was significantly lower than that in control group (P〈0. 01). On the other hand, the plasmic pro-BNP in the tumor the group was significantly higher than that in the control group at both the two time sites(P〈0. 01). Conclusion The plasmic pro-BNP level can reflect the left ventricle function of presby-tumor patients to some extent and its sensibility is higher than UCG and can be used as a risk assessment tool for estimating the presby-tumor patients' risk of having a heart failure at the early stage.
出处 《重庆医学》 CAS CSCD 2006年第22期2063-2064,共2页 Chongqing medicine
关键词 脑利钠肽前体 老年人 肿瘤 心力衰竭 pro-BNP gerontal patient tumour heart failure
  • 相关文献

参考文献7

  • 1Nathan Ⅰ Cherny.ESMO's new direction in supportive and palliative care[J].Arch Oncol,2004,12(3):163
  • 2张铖,叶平.炎性细胞因子与左心室重构[J].国外医学(老年医学分册),2004,25(1):29-32. 被引量:4
  • 3Sudoh T,Kangawa K,Minamina N,et al.A new natriuretic peptide in porcine brain[J].Nature,1988,332:78
  • 4Maisel S,Koon J,Krishnaswamy P,et al.Utility of BNP as a rapid,point of care test for screening patients undergoing echocardiography to determine left ventricular dysfunction[J].Am Heart J,2001,14(30):367
  • 5Maede K,Ta K,Ayoshi T,et al.High level of plasma brain natriuretic peptide and interlekin 6 after optimizedt reatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure[J].J Am Coll Cardiac,2001,36(5):1587
  • 6Colucci S,El U,Horton P,et al.Intravenous nesiritide a nat riuretic peptide in the treament of decompensated congestive heart failure[J].New Engl J Med,2000,343(4):246
  • 7陈纯波,孙诚,吴粤.充血性心力衰竭患者血浆N-端脑利钠肽前体水平的变化[J].实用医学杂志,2005,21(11):1164-1165. 被引量:20

二级参考文献24

  • 1Siwik DA, Chang DLF, Colucci WS. Interleukin- 1β and tumor necrosis factor - a decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Cric Res, 2000; 86 (12): 1259-1265.
  • 2Bond M, Chase AJ, Baker AH et al. Inhibition of transcription factor NF- kappaB reduces matrix metalloproteinase- 1,- 3, and - 9 production by vascular smooth cells. Cardiovasc Res, 2001; 50 (3): 556-565.
  • 3Uchida M, Shima M, Shimoaka T et al. Regulation of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. J Cell Physid, 2000; 185 (2): 207-214.
  • 4Bondeson J, Brennan F, Foxwell B et al. Effective adenoviral transfer of Iκ Ba into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor -κB dependent. J Rheumatol, 2000; 27 (9): 2078-2089.
  • 5Li YY, Feng YQ, Kadokami T et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor a can be modulated by anti - tumor necrosis factor a therapy. Proc Natl Acad Sci USA, 2000; 97 (23) :12746- 12751.
  • 6Bradham WS, Gordon M, Katherine A et al. TNF α and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling. Am J Physiol Heart. Circ Physiol,2002; 282 (4): H1288-H1295.
  • 7Shiol T, Mateumori A, Kakio T et al. Proinflammatory cytokine inhibitor prolongs the survival of rats with heart failure induced by pressure overload. Jpn Circ J, 2001; 65 (6):584- 585.
  • 8Kadoakmi T, Frye C, Lemster Bet al. Anti - Tumor necrosis factor - a antibody limits heart failure in a transgenic model. Circulation, 2001; 104 (10) : 1094- 1097.
  • 9Dehend R, Fiebeler A, Park J et al. Amelioration of angiotensin Ⅱ - induced cardiac injury by a 3 - hydroxy- 3 -methylglutaryl coenzyme A reductase inhibitor. Circulation,2001; 104 (5): 576-581.
  • 10Su SF, Hsiao C, Chu CW et al. Effect of pravastatin on left ventrieular mass in patients with hyperlipidemia and essential hypertension. Am J Cardiol, 2000; 86 (5): 514-518.

共引文献22

同被引文献13

引证文献1

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部